Key facts: American Well Targets Rise; Hold Consensus, 2% Upside
Analysts at TD Cowen and Stifel maintained Hold ratings on American Well (AMWL) but raised their price targets to $13 and $12, respectively. The average 12-month price target increased to $13, suggesting 2% upside from the Nov. 3 close. The consensus remains Hold with one Buy, seven Holds, and no Sells.
How this was made

The 30-second read
Why it matters
Target upgrades can attract short-term buying interest, but the modest 2% upside limits large moves.
Market read
Small but fresh analyst upgrades for AMWL provide a modest trading cue.
What to watch
Potential regulatory changes and reimbursement uncertainties could limit upside.
Background
Analyst firms periodically update price targets based on earnings, guidance, and market conditions.
Ticker impact
TD Cowen and Stifel raised AMWL price targets to $13 and $12 respectively, implying ~2% upside.
likely slight upward pressure as investors price in the new targets
Target raises are fresh and directly indicate a bullish view, but the magnitude is small.
Market effects
Minor positive signal for the telehealth sector as analysts see modest upside.
US market focus; limited broader regional effect.
Low global relevance; impact confined to AMWL and its peers.
Counterpoint
The target increase may be premature given competitive pressures in telehealth.
Key entities
- Analyst FirmTD Cowen
Raised AMWL price target to $13.
- Analyst FirmStifel
Raised AMWL price target to $12.


